PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 116 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 4.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $197,000 | -79.0% | 74,050 | -55.8% | 0.02% | -77.9% |
| Q3 2018 | $939,000 | -44.6% | 167,711 | -49.8% | 0.07% | -44.3% |
| Q2 2018 | $1,694,000 | +158.2% | 334,155 | +247.4% | 0.12% | +149.0% |
| Q1 2018 | $656,000 | -66.3% | 96,190 | -62.7% | 0.05% | -65.7% |
| Q4 2017 | $1,946,000 | +57.2% | 257,779 | +19.9% | 0.14% | +70.2% |
| Q3 2017 | $1,238,000 | – | 214,934 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |